SCHEMBL9170818

SCHEMBL9170818

COc1ccc([C@H]2C[C@@]3(C)[C@@H](C=C[C@@]3(O)C#CCOC3CCCCO3)[C@@H]3CC=C4CC5(CC[C@@H]4[C@H]32)OCCO5)cc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9173750 0.85 NR3C1 (0.35) —
SCHEMBL9175483 0.81 NR3C1 (0.45) —
SCHEMBL8768992 0.81 PGR (0.32) —
SCHEMBL9173987 0.79 — —
SCHEMBL9171310 0.78 NR3C1 (0.30) —
SCHEMBL8767925 0.77 PGR (0.31) —
SCHEMBL8768825 0.77 — —
SCHEMBL8768115 0.76 PGR (0.30) —
SCHEMBL8767729 0.76 — —
SCHEMBL9173953 0.75 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5426102-A Antigestagenic, antiandrogenic, antiglucocorticoid, antimineralcorticoid properties SCHERING AKTIENGESELLSCHAFT (DE) 1995-06-20 — — US disclosed
Send feedback